Dog /

Breed profile · FDA CVM July 2026 extract

Spitz - American Eskimo Dog adverse-event record

Adverse-event filings for Spitz - American Eskimo Dog (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#105 of 510
by report volume (all breeds)
1,149
FDA CVM reports on file
4.6%
death-coded share of reports
#147 of 275
by death-coded share (≥50 reports)

How the 1,149 reports break down

By recorded gender -- every report on file for Spitz - American Eskimo Dog, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 82 61.5 41 20.5 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Spitz - American Eskimo Dog drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Spitz - American Eskimo Dog ranks #105 of 510 by total reports (1,149) and #147 of 275 by death-coded share (4.6%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#105
This breed, reports of 510
#147
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Spitz - American Eskimo Dog has 1,149 reports now versus 1,141 in that prior snapshot: 8 more (0.7%).

Report change
+8
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Spitz - American Eskimo Dog changes

Total Reports

1,149

High report volume

Deaths Reported

53

of 1,149 reports

Death-coded share of reports

4.6%

Below-median death-coded share

Avg Age at Report

7.2 yr

11.7 kg avg weight

Breed Safety Scorecard

C (59/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate D
4.6%

Share of reports coded as a fatality

Euthanasia rate D
2.3%

Share of reports resulting in euthanasia

Full recovery rate B
34.2%

Share of reports coded "Recovered/Normal"

5-year trend B
-13%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Spitz - American Eskimo Dog death-coded reports 4.6%
Cross-breed median

4.6% of 1,149 spitz - american eskimo dog reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Spitz - American Eskimo Dog's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

5% 47th percentile Higher share than 47% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Spitz - American Eskimo Dog 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 11.7 kg (25.8 lbs)

Top Reported Reactions

Vomiting 274
Lethargy (see also Central nervous system depression in 'Neurological') 118
Diarrhoea 102
Emesis 102
Lack of efficacy (ectoparasite) - flea 76
Seizure NOS 68
Lack of efficacy - NOS 52
Lack of efficacy (endoparasite) - hookworm 49
Anorexia 47
Digestive tract disorder NOS 40
Behavioural disorder NOS 35
INEFFECTIVE, HEARTWORM LARVAE 31
Elevated blood urea nitrogen (BUN) 29
Ataxia 27
Other abnormal test result NOS 26

Most Referenced Drugs

Milbemycin Oxime + Spinosad 192
Spinosad 96
Afoxolaner 89
Ivermectin + Pyrantel As Pamoate Salt 84
Fluralaner Chew Tablets 53
Trilostane 50
Moxidectin 39
Sarolaner 38
Milbemycin Oxime + Praziquantel 37
Pyrantel Pamoate;Sarolaner 35
Carprofen 33
Fluralaner 13.64% 12-Week Chew 31
Bedinvetmab 23
Selamectin 21
Imidacloprid + Moxidectin 17

Outcome Breakdown

Recovered/Normal
393 (37.8%)
Outcome Unknown
340 (32.7%)
Ongoing
208 (20.0%)
Recovered with Sequela
45 (4.3%)
Died
27 (2.6%)
Euthanized
26 (2.5%)

Gender Distribution

Female 566 (49.3%)
Male 565 (49.2%)
Unknown 16 (1.4%)
Mixed 2 (0.2%)

Reports by Year

Year Reports Trend
2010 66
2011 74
2012 91
2013 97
2014 93
2015 95
2016 80
2017 78
2018 72
2019 82
2020 78
2021 54
2022 35
2023 43
2024 59
2025 47
2026 5

Spitz - American Eskimo Dog: high-volume FDA adverse-event cohort

Signature read: 1,149 reports place Spitz - American Eskimo Dog in the upper third of breed filing volume (#105 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Spitz - American Eskimo Dog sits at #105 of 510 by report volume among all breeds and #87 of 298 among dog breeds, with 1,149 reports and 53 (4.6%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #147 of 275. Mean age at report: 7.2 years, average weight 11.7 kg (25.8 lbs).

Top reported signs: Vomiting (274), Lethargy (see also Central nervous system depression in 'Neurological') (118), Diarrhoea (102). Most-referenced drug: Milbemycin Oxime + Spinosad (192 reports), followed by Spinosad (96) and Afoxolaner (89).

Outcome coding on 1,039 status-recorded reports is dominated by Recovered/Normal (37.8%). Annual submissions ranged 5-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Spitz - American Eskimo Dog drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (4.6% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (11.7 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Spitz - American Eskimo Dog?
There are 1,149 adverse event reports involving Spitz - American Eskimo Dog in the FDA database, of which 53 were death-coded (4.6% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Spitz - American Eskimo Dog ranks #105 of 510 by report volume among all breeds PlainBreed indexes (#87 of 298 among dog breeds).
Where does Spitz - American Eskimo Dog sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Spitz - American Eskimo Dog is #105 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #87 of 298. Among breeds with at least 50 reports, its death-coded share ranks #147 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Spitz - American Eskimo Dog?
The most commonly reported adverse reactions for Spitz - American Eskimo Dog are Vomiting (274 reports), Lethargy (see also Central nervous system depression in 'Neurological') (118 reports), Diarrhoea (102 reports), Emesis (102 reports), Lack of efficacy (ectoparasite) - flea (76 reports).
What drugs are most frequently associated with Spitz - American Eskimo Dog adverse events?
The drugs most frequently referenced in Spitz - American Eskimo Dog adverse event reports are Milbemycin Oxime + Spinosad (192 reports), Spinosad (96 reports), Afoxolaner (89 reports), Ivermectin + Pyrantel As Pamoate Salt (84 reports), Fluralaner Chew Tablets (53 reports).
What is the average age of Spitz - American Eskimo Dog in adverse event reports?
The average age of Spitz - American Eskimo Dog at the time of adverse event reports is 7.2 years, with an average weight of 11.7 kg (25.8 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Spitz - American Eskimo Dog (Dog), extract as of July 2026 extract. 1,149 reports · 53 death-coded (4.6% of reports, not a mortality rate) · #105 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →